CDSCO registration for overseas medical device manufacturers is an important regulatory requirement for foreign companies intending to import and market medical devices in India. Under the Medical Devices Rules, 2017 (MDR 2017), overseas manufacturers generally need to obtain an import licence from the Central Licensing Authority. The application is submitted in Form MD-14 and, when approved, the import licence is granted in Form MD-15.
An overseas manufacturer must appoint an Indian Authorized Agent (IAA) to undertake the applicable regulatory process in India. The application is submitted online through the CDSCO medical-device online/SUGAM system and must be supported by the documents prescribed under MDR 2017 and the applicable CDSCO checklist.
The documentation may include the Power of Attorney, Indian Authorized Agent documents, Free Sale Certificate or Marketing Authorization where applicable, manufacturing-site certificates, quality-management documentation, Plant Master File, Device Master File, labeling and other technical information. The exact documentation depends on the medical device and applicable regulatory requirements.
Under MDR 2017, medical devices imported into India for marketing are regulated by the Central Licensing Authority.
For a standard import-licence application:
CDSCO's Medical Device Division specifically identifies the MD-14 application and MD-15 import-licence process for imported medical devices.
The CDSCO FAQ also states that an importer intending to import medical devices for marketing in India is required to obtain an import licence under MDR 2017, subject to the applicable provisions and exemptions.
Although the process is sometimes referred to informally as “CDSCO registration for foreign medical device manufacturers,” the principal regulatory approval for importing medical devices for marketing in India is the CDSCO import licence in Form MD-15.
Therefore, terms such as:
may be used for search purposes, but the regulatory terminology should be kept precise throughout the article.
An overseas manufacturer does not simply submit an MD-14 application independently without an Indian regulatory representative.
The manufacturer appoints an Indian Authorized Agent through a Power of Attorney. The CDSCO Form MD-14 checklist requires the Power of Attorney and undertaking from the Authorized Agent in accordance with Part I of the Fourth Schedule of MDR 2017.
The CDSCO checklist also requires a copy of the Authorized Agent's:
as applicable.
The application should also contain the constitution details of the Authorized Agent.
The basic process can be summarized as follows:
The overseas manufacturer appoints an eligible Indian Authorized Agent through a Power of Attorney.
The manufacturer and Authorized Agent should identify the applicable requirements based on:
The dossier should include the applicable administrative documents, regulatory certificates, quality documents, Plant Master File, Device Master File, labeling and other supporting information.
The Power of Attorney must comply with the authentication requirements under Part I of the Fourth Schedule.
CDSCO states that the application for an import licence is made in Form MD-14 through the SUGAM online portal.
The prescribed fee is paid in accordance with the applicable provisions of the Second Schedule of MDR 2017.
CDSCO may examine the application and raise queries or request additional information. The Authorized Agent and manufacturer should provide appropriate responses and supporting documents.
After the applicable requirements are satisfied, the Central Licensing Authority may grant the import licence in Form MD-15.
The CDSCO checklist for a fresh Form MD-14 application identifies the following major categories of documents.
A covering letter should accompany the application and clearly identify the:
The information in the covering letter should be consistent with the Form MD-14 application and supporting documents.
The applicant must submit the prescribed Form MD-14 application for grant of an import licence.
The form contains important product and manufacturer information, including:
MDR 2017 provides the prescribed Form MD-14 format and identifies the documents required under the Fourth Schedule.
The applicable fee must be paid in accordance with the Second Schedule of MDR 2017.
The application should include the relevant fee challan, receipt or transaction details as required.
The Power of Attorney (PoA) is one of the most important documents in an overseas manufacturer's CDSCO application.
The CDSCO checklist requires the Power of Attorney together with an undertaking from the Authorized Agent in accordance with Part I of the Fourth Schedule of MDR 2017.
The Power of Attorney must be authenticated in India through one of the methods specified by the regulations, including:
The exact execution and authentication process should be checked before preparing the final document.
The application should include the Authorized Agent's applicable licence or registration document, such as:
The CDSCO checklist also requires the constitution details of the Authorized Agent.
Depending on the applicant's legal structure, supporting corporate and address documentation may be required to establish the identity and constitution of the Authorized Agent.
The regulatory certificate section of the CDSCO MD-14 checklist includes:
These documents provide information regarding the regulatory status and marketability of the product and manufacturing facility.
Importantly, the availability and applicability of a particular certificate should be assessed against the current CDSCO checklist and the specific device rather than assuming that every certificate is mandatory for every application.
The CDSCO checklist requires a copy of the overseas manufacturing site, establishment or plant registration issued by the competent authority in the country of origin, where applicable to the regulatory documentation. The checklist specifies that this document should be duly notarized.
The manufacturer's:
should remain consistent across the application dossier.
The CDSCO checklist refers to the latest inspection or audit report carried out by the competent authority within the previous three years, if any.
Where such a report is available and applicable, it should be reviewed for consistency with the manufacturing-site information and quality-system documentation submitted in the application.
The CDSCO checklist includes quality documentation relating to the actual manufacturing site, as applicable. It identifies:
The checklist also refers to a Declaration of Conformity issued by the manufacturer.
An ISO 13485 certificate is an important quality-management document for medical-device regulatory submissions. However, the exact quality documentation required should be determined according to the current CDSCO checklist and the specific product and manufacturing arrangement.
The certificate should clearly correspond to the relevant manufacturing site and legal entity where applicable.
The Plant Master File (PMF) is a core component of the import-licence dossier.
Under the CDSCO checklist, the Plant Master File is to be prepared by the manufacturer in accordance with Appendix I of the Fourth Schedule of MDR 2017.
The PMF provides information about the manufacturing facility and may cover areas such as:
The PMF should accurately represent the actual manufacturing facility and its operations.
The Device Master File (DMF) is the product-specific technical component of the application.
The CDSCO checklist requires the Device Master File in accordance with Appendix II of the Fourth Schedule of MDR 2017.
Depending on the device and applicable regulatory pathway, the DMF may include:
Depending on the device, the technical dossier may include:
Depending on the device and applicable regulatory pathway, the dossier may require:
The exact technical evidence should be determined based on the device and applicable CDSCO requirements rather than applying one identical evidence package to every medical device.
Product labels and Instructions for Use are important components of the import-licence dossier.
The information should be consistent with the:
Any differences between the technical dossier and proposed Indian labeling can result in regulatory queries.
One of the most important practical aspects of a CDSCO application is document consistency.
The following information should be carefully cross-checked across the dossier:
For example, if the manufacturing-site address on the ISO 13485 certificate differs from the address stated in the Plant Master File, the applicant may need to provide clarification or additional supporting documentation.
The overall process can be summarized as:
1. Overseas manufacturer appoints Indian Authorized Agent
↓
2. Device classification and regulatory assessment
↓
3. Preparation of regulatory and technical documentation
↓
4. Preparation and authentication of Power of Attorney
↓
5. Preparation of PMF and DMF
↓
6. Online submission of Form MD-14
↓
7. Payment of applicable fee
↓
8. CDSCO review and regulatory queries, if any
↓
9. Submission of responses/additional documents
↓
10. Grant of Form MD-15 import licence, when approved
CDSCO identifies Form MD-14 as the online application route for grant of the Form MD-15 import licence.
The processing time can depend on factors such as:
Therefore, applicants should avoid promising a fixed approval timeline unless it is supported by the applicable regulatory provision.
A complete and internally consistent dossier can help reduce avoidable queries and documentation-related delays.
The Form MD-15 import licence is subject to the retention-fee requirements under MDR 2017.
The applicable retention fee must be paid at the prescribed intervals to maintain the validity of the licence. Applicants should verify the current fee and retention requirements before making payment.
The licence should also be maintained in accordance with applicable post-approval regulatory requirements.
Obtaining the MD-15 import licence is not the end of the regulatory process.
The overseas manufacturer and Indian Authorized Agent must continue to comply with applicable requirements, which may include:
Changes to the manufacturer, manufacturing site, product specifications, models, labeling or other approved information should be assessed for their regulatory impact before implementation.
Overseas manufacturers should avoid the following common documentation issues:
Using an incorrect classification can affect the regulatory pathway and technical documentation.
The manufacturer's legal name and address should be consistent across regulatory certificates and the CDSCO dossier.
The PoA must follow the applicable Fourth Schedule requirements and authentication process.
The technical files should be prepared according to the applicable Fourth Schedule requirements.
Applicants should ensure that certificates and supporting documents remain current and relevant.
Model numbers in the MD-14 application, labels, certificates and technical documents should be carefully reconciled.
The intended use should remain consistent across the regulatory dossier and labeling.
The CDSCO checklist contains documents that are applicable depending on the product and circumstances. Applicants should use the current checklist applicable to their application rather than relying on a generic document list.
Obtaining a CDSCO import licence for an overseas medical device manufacturer requires coordinated preparation of administrative, regulatory and technical documentation.
MDR CONSULTANTS provides regulatory support to overseas medical device manufacturers seeking to import and market medical devices in India.
Our support can include:
Our objective is to help manufacturers prepare a complete, consistent and appropriately documented submission aligned with the applicable CDSCO requirements.
Our regulatory team can conduct a detailed review of existing international regulatory documentation and identify areas requiring alignment with Indian requirements.
This may include reviewing:
For manufacturers entering the Indian market for the first time, this structured approach can help identify documentation gaps before the Form MD-14 application is submitted.
Obtaining a CDSCO import licence for an overseas medical device manufacturer requires careful preparation of Form MD-14 and the supporting documentation prescribed under the Medical Devices Rules, 2017.
The principal documentation categories can include:
CDSCO's published checklist specifically identifies the Power of Attorney, Authorized Agent documents, regulatory certificates, quality certificates, Plant Master File and Device Master File among the key components of a fresh MD-14 application.
The application is submitted online through the CDSCO/SUGAM system, with Form MD-14 serving as the application for the import licence and Form MD-15 being the licence issued upon approval.
Because CDSCO requirements, checklists and online procedures can be updated, overseas manufacturers should verify the latest Medical Devices Rules, 2017, CDSCO checklists, notifications and portal instructions before filing.
For regulatory support with CDSCO import licensing, MD-14/MD-15 applications, Plant Master Files, Device Master Files and Indian Authorized Agent coordination, MDR CONSULTANTS can assist overseas medical device manufacturers throughout the Indian regulatory process.
Last Updated : 19 Sep 2026
The Brand That Promises To Turn Your Business Around!